1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Norway, September 2016

Pharmaceutical Analysis & Statistics in Norway, September 2016

1-30 of 60 reports

Purchase Reports From Reputable Market Research Publishers

Norway Pharmaceuticals and Healthcare Report Q3 2016

Norway Pharmaceuticals and Healthcare Report Q3 2016

  • $ 1 300
  • Industry report
  • July 2016
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Norway's life sciences and biomedical research base will continue to develop at a sustainedpace, which will enhance investment opportunities over the medium ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
Norway’s ICT Spends in Pharmaceuticals Sector - Future Perspective to 2019

Norway’s ICT Spends in Pharmaceuticals Sector - Future Perspective to 2019

  • $ 500
  • Industry report
  • August 2016
  • by Kable

Summary Norway's ICT Spends in Pharmaceuticals Sector - Future Perspective to 2019; is an exhaustive research report outlaying future perspectives of ICT project spends in Norway. The report provides yea ...

  • Industries : Pharmaceutical
  • Countries : Norway
NorDiag ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

NorDiag ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Countries : Norway, United Kingdom
Algeta ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Algeta ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Norway, United Kingdom
Navamedic ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navamedic ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : United Kingdom, Norway
Biotec Pharmacon ASA

Biotec Pharmacon ASA

  • $ 99
  • Company report
  • September 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Biotec Pharmacon ASA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : Norway
Bionor Pharma ASA

Bionor Pharma ASA

  • $ 99
  • Company report
  • September 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Bionor Pharma ASA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : Norway
Photocure ASA

Photocure ASA

  • $ 99
  • Company report
  • September 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Photocure ASA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : Norway
2016-2020 Norway Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emerging O

2016-2020 Norway Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emerging O

  • $ 2 450
  • Industry report
  • May 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ...

  • Industries : Therapy
  • Countries : Norway
Norway Pharmaceuticals and Healthcare Report Q2 2016

Norway Pharmaceuticals and Healthcare Report Q2 2016

  • $ 1 300
  • Industry report
  • April 2016
  • by Business Monitor International

Includes 3 FREE quarterly updates

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway

  • $ 1 610
  • Industry report
  • March 2016
  • by IMS Health

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of ...

  • Industries : Therapy, Pharmaceutical
  • Countries : Norway
KAEL Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

KAEL Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
  • Countries : Norway
DiaGenic ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

DiaGenic ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : Norway
Aqualis ASA (formerly Clavis Pharma ASA) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Aqualis ASA (formerly Clavis Pharma ASA) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : Norway
Pronova BioPharma ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Pronova BioPharma ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : United States, United Kingdom, Norway
Norway Pharmaceuticals and Healthcare Report Q1 2016

Norway Pharmaceuticals and Healthcare Report Q1 2016

  • $ 1 300
  • Industry report
  • January 2016
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Norway's 2016 fiscal stimulus is expected to be positive in terms of supporting thepharmaceutical and healthcare sector growth trajectory Over the long term, ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
Targovax AS - Product Pipeline Review - 2015

Targovax AS - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • December 2015
  • by Global Markets Direct

Targovax AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Targovax AS - Product Pipeline Review - 2015’, provides an overview of the Targovax AS’s pharmaceutical research and ...

  • Industries : Therapy, Research and Development, Biological Therapy
  • Countries : World, Norway, United States
Industrial Construction in Norway to 2019: Market Forecast

Industrial Construction in Norway to 2019: Market Forecast

  • $ 950
  • Industry report
  • December 2015
  • by Timetric

Synopsis Timetric’s 'Industrial Construction in Norway to 2019: Market Forecast' contains detailed historic and forecast market value data for the industrial construction industry, including a breakdown ...

  • Industries : Non-Residential Construction, Construction, Pharmaceutical
  • Countries : Norway, Europe
Vaccibody AS - Product Pipeline Review - 2015

Vaccibody AS - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • November 2015
  • by Global Markets Direct

Vaccibody AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Vaccibody AS - Product Pipeline Review - 2015’, provides an overview of the Vaccibody AS’s pharmaceutical research ...

  • Industries : Biopharmaceutical, Therapy, Biological Therapy, Biotechnology, Research and Development
  • Countries : Norway
Digestive Remedies in Norway

Digestive Remedies in Norway

  • $ 992
  • Industry report
  • November 2015
  • by Euromonitor International

Increased exposure to the internet and various social media platforms has created a much more informed average consumer in Norway. Purchasing decisions are no longer completely influenced by doctors, with ...

  • Industries : OTC
  • Countries : Norway
Cough, Cold and Allergy (Hay Fever) Remedies in Norway

Cough, Cold and Allergy (Hay Fever) Remedies in Norway

  • $ 992
  • Industry report
  • November 2015
  • by Euromonitor International

Medicated confectionery continued to perform well in 2015, posting current value growth of 4% to reach sales of NOK866 million and help drive the wider category. Although it is accepted that many of the ...

  • Industries : OTC
  • Countries : Norway
Vitamins and Dietary Supplements in Norway

Vitamins and Dietary Supplements in Norway

  • $ 992
  • Industry report
  • November 2015
  • by Euromonitor International

The media plays a huge role in the way that vitamins and dietary supplements are consumed in Norway, with this having had a negative effect over the last three years. Norwegian consumers spend a lot of ...

  • Industries : OTC
  • Countries : Norway
Adult Mouth Care in Norway

Adult Mouth Care in Norway

  • $ 992
  • Industry report
  • November 2015
  • by Euromonitor International

Both the mass and social media became increasingly important in driving the sales of adult mouth care products in Norway in 2015. While previously most Norwegians were not aware of the connection between ...

  • Industries : OTC
  • Countries : Norway
Herbal/Traditional Products in Norway

Herbal/Traditional Products in Norway

  • $ 992
  • Industry report
  • November 2015
  • by Euromonitor International

The internet is playing an increasingly important role in the way that Norwegians consume herbal/traditional products, and this has begun to have an adverse effect over the last three years. While there ...

  • Industries : OTC
  • Countries : Norway
Sports Nutrition in Norway

Sports Nutrition in Norway

  • $ 992
  • Industry report
  • November 2015
  • by Euromonitor International

The general health and wellness trend continued to be the most important driver of sales in sports nutrition in 2015. As Norwegian consumers increasingly recognise the value of eating well and exercising, ...

  • Industries : OTC
  • Countries : Norway
NRT Smoking Cessation Aids in Norway

NRT Smoking Cessation Aids in Norway

  • $ 992
  • Industry report
  • November 2015
  • by Euromonitor International

NRT smoking cessation aids in 2015 continued to be influenced by various anti-smoking regulations, pricing and social stigma. Smoking continued to be illegal in public and work places, while the average ...

  • Industries : OTC
  • Countries : Norway
Analgesics in Norway

Analgesics in Norway

  • $ 1 023
  • Industry report
  • November 2015
  • by Euromonitor International

Media reports on the dangers of various analgesics played a key role in the performance of the different categories in 2015. Most notable were the various feelings expressed against ibuprofen, these contributing ...

  • Industries : OTC
  • Countries : Norway
Weight Management in Norway

Weight Management in Norway

  • $ 992
  • Industry report
  • November 2015
  • by Euromonitor International

The health and wellness trend has gripped Norway over the last three years, with Norwegian consumers placing an increasing emphasis on eating well, exercising and generally leading healthy lives. While ...

  • Industries : OTC
  • Countries : Norway
Consumer Health in Norway

Consumer Health in Norway

  • $ 2 635
  • Industry report
  • November 2015
  • by Euromonitor International

Consumer health in Norway continued to perform solidly in 2015 in current value terms. Positive growth continued to be driven by the fact that most Norwegian consumers have strong disposable incomes, a ...

  • Industries : OTC
  • Countries : Norway
Weifa AS in Consumer Health (Norway)

Weifa AS in Consumer Health (Norway)

  • $ 143
  • Industry report
  • November 2015
  • by Euromonitor International

Weifa plans to solidify its position in the OTC category in Norway by maintaining its lead in analgesics and becoming a top three player in cough, cold and allergy (hay fever) remedies through the continued ...

  • Industries : Therapy, OTC, Healthcare, Pharmaceutical
  • Countries : Norway

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.